High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients.

Source:http://linkedlifedata.com/resource/pubmed/id/21299340

Download in:

View as

General Info

PMID
21299340